Application of Oxford classification, and overexpression of transforming growth factor-β1 and immunoglobulins in immunoglobulin A nephropathy: Correlation with World Health Organization classification of immunoglobulin A nephropathy in a Chinese patient cohort

Translational Research

Volumn 163, Issue 1, 2014, Pages 8-18

  Meng, Hongxue ^a,b   Zhang, Lei ^b   Xiaoqiang, E ^b   Ye, Fei ^b   Li, Huining ^c   Han, Changsong ^b   Yamakawa, Mitsunori ^a   Jin, Xiaoming ^b  

^a YAMAGATA UNIVERSITY   (Japan)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c University of Hei Longjiang   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN A1; MESSENGER RNA; SECRETORY IMMUNOGLOBULIN; TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHINESE; COHORT ANALYSIS; COMPLEMENT DEPOSITION; CONTROLLED STUDY; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOCAL GLOMERULOSCLEROSIS; HEMATURIA; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OXFORD CLASSIFICATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEINURIA; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; WORLD HEALTH ORGANIZATION CLASSIFICATION; YOUNG ADULT;

EID: 84890503225     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2013.06.007     Document Type: Article

References (34)

1. J.V. Donadio, and J.P. Grande IgA nephropathy N Engl J Med 347 2002 738 748 (Pubitemid 35203906)
2. J.J. Dillon Treating IgA nephropathy J Am Soc Nephrol 12 2001 846 847 (Pubitemid 32246714)
3. F.D. Zhou, M.H. Zhao, W.Z. Zou, G. Liu, and H. Wang The changing spectrum of primary glomerular diseases within 15 years: a survey of 3331 patients in a single Chinese centre Nephrol Dial Transplant 24 2008 870 876
4. M. Haas Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases Am J Kidney Dis 29 1997 829 842 (Pubitemid 27251835)
5. S.M. Lee, V.M. Rao, and W.A. Franklin IgA nephropathy: morphologic predictors of progressive renal disease Hum Pathol 13 1982 314 322 (Pubitemid 12105183)
6. C. Manno, G.F. Strippoli, C. D'Altri, D. Torres, M. Rossini, and F.P. Schena A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study Am J Kidney Dis 49 2007 763 775 (Pubitemid 46802935)
7. M. Goto, K. Wakai, T. Kawamura, M. Ando, M. Endoh, and Y. Tomino A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study Nephrol Dial Transplant 24 2009 3068 3074
8. D.C. Cattran, R. Coppo, and H.T. Cook The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification Kidney Int 76 2009 534 545
9. I.S. Roberts, H.T. Cook, and S. Troyanov The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility Kidney Int 76 2009 546 556
10. C.A. Chen, J.C. Hwang, J.Y. Guh, J.C. Tsai, and H.C. Chen TGF-beta1 and integrin synergistically facilitate the differentiation of rat podocytes by increasing alpha-smooth muscle actin expression Transl Res 148 2006 134 141
11. H.S. Lee Mechanisms and consequences of TGF-β overexpression by podocytes in progressive podocyte disease Cell Tissue Res 347 2012 129 140
12. A.B. Fogo, and M. Kashgarian IgA nephropathy G.Y. Zhou, Diagnostic atlas of renal pathology 2007 Peking University Medical Press Peking 85 95
13. C. Miyake-Ogawa, M. Miyazaki, and K. Abe Tissue-specific expression of renin-angiotensin system components in IgA nephropathy Am J Nephrol 25 2005 1 12 (Pubitemid 40529270)
14. C.H. Zeng, W. Le, and Z. Ni A multicenter application and evaluation of the Oxford classification of IgA nephropathy in adult Chinese patients Am J Kidney Dis 60 2012 812 820
15. N. Mittal, K. Joshi, S. Rane, R. Nada, and V. Sakhuja Primary IgA nephropathy in north India: is it different? Postgrad Med J 88 2012 15 20
16. S.H. Kang, S.R. Choi, and H.S. Park The Oxford classification as a predictor of prognosis in patients with IgA nephropathy Nephrol Dial Transplant 27 2012 252 258
17. A.M. Herzenberg, A.B. Fogo, and H.N. Reich Validation of the Oxford classification of IgA nephropathy Kidney Int 80 2011 310 317
18. E. Alamartine, C. Sauron, and B. Laurent The use of the Oxford classification of IgA nephropathy to predict renal survival Clin J Am Soc Nephrol 6 2011 2384 2388
19. H.S. Hwang, B.S. Kim, and Y.S. Shin Predictors for progression in immunoglobulin A nephropathy with significant proteinuria Nephrology 15 2010 236 241
20. Z. Al-Aly, and O. Cepeda Rate of change in kidney function and the risk of death: the case for incorporating the rate of kidney function decline into the CKD staging system Nephron Clin Pract 119 2011 179 185
21. Z. Al-Aly, V. Reddivari, and A. Moiz Renal allograft biopsies in the era of C4d staining: the need for change in the Banff classification system Transpl Int 21 2008 268 275 (Pubitemid 351197355)
22. S.M. Kim, H.J. Chin, Y.K. Oh, Y.S. Kim, S. Kim, and C.S. Lim Blood pressure-related genes and the progression of IgA nephropathy Nephron Clin Pract 113 2009 301 308
23. J.A. Vassalotti, C.H. Fox, and B.N. Becker Risk factors and screening for chronic kidney disease Adv Chronic Kidney Dis 17 2010 237 245
24. F. Aucella, G.S. Netti, M. Piemontese, I.R. Cincione, B. Infante, and L. Gesualdo Proteinuria in the prognosis of IgA nephropathy Minerva Urol Nephrol 61 2009 235 248
25. T.E. Mollnes, W.C. Song, and J.D. Lambris Complement in inflammatory tissue damage and disease Trends Immunol 23 2002 61 64 (Pubitemid 34310141)
26. A. Sahu, D. Morikis, and J.D. Lambris Compstatin, a peptide inhibitor of complement, exhibits species-specific binding to complement component C3 Mol Immunol 39 2003 557 566 (Pubitemid 35335834)
27. J. Berger, and N. Hinglais Intercapillary deposits of IgA-IgG J Urol Nephrol 74 1968 694 695
28. J. Stavnezer, and J. Kang The surprising discovery that TGF beta specifically induces the IgA class switch J Immunol 182 2009 5 7
29. K. Watanabe, M. Sugai, and Y. Nambu Requirement for Runx proteins in IgA class switching acting downstream of TGF-beta 1 and retinoic acid signaling J Immunol 184 2010 2785 2792
30. Y. Nishikawa, R. Shibata, and Y. Ozono Streptococcal M protein enhances TGF-beta production and increases surface IgA-positive B cells in vitro in IgA nephropathy Nephrol Dial Transplant 15 2000 772 777 (Pubitemid 30311993)
31. R. Sam, L. Wanna, and K.P. Gudehithlu Glomerular epithelial cells transform to myofibroblasts: early but not late removal of TGF-beta1 reverses transformation Transl Res 148 2006 142 148 (Pubitemid 44287634)
32. C.Y. Song, B.C. Kim, and H.S. Lee Lovastatin inhibits oxidized low-density lipoprotein-induced plasminogen activator inhibitor and transforming growth factor-beta1 expression via a decrease in Ras/extracellular signal-regulated kinase activity in mesangial cells Transl Res 151 2008 27 35 (Pubitemid 350167046)
33. S. Das, B.N. Becker, F.M. Hoffmann, and J.E. Mertz Reversal of transforming growth factor-β induced epithelial-to-mesenchymal transition and the ZEB proteins Fibrogenesis Tissue Repair 5 Suppl 1 2012 S28
34. Snyder M.R.,Clark R.,Bryant S.C.,Katzmann J.A., Quantification of urinary light chains, Clin Chem, 2008, 54, 1744-1746